Standout Papers
- Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007)
- Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis (1999)
- Survey of Infections Due toStaphylococcusSpecies: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997–1999 (2001)
- Attributable Mortality of Nosocomial Candidemia, Revisited (2003)
- Resistance of Candida species to fluconazole (1995)
- Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry (2009)
- Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections (1997)
- Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment (2011)
- Epidemiology of Invasive Mycoses in North America (2010)
- Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations (2013)
- Epidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance Registry (2008)
- Intranasal Mupirocin to Prevent PostoperativeStaphylococcus aureusInfections (2002)
- Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion (2010)
- Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016 (2019)
- Rare and Emerging Opportunistic Fungal Pathogens: Concern for Resistance beyondCandida albicansandAspergillus fumigatus (2004)
- "White-opaque transition": a second high-frequency switching system in Candida albicans (1987)
- Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012 (2012)
- The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program (2019)
Immediate Impact
3 by Nobel laureates 16 from Science/Nature 127 standout
Citing Papers
Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysis
2024 Standout
Structural and mechanistic insights into fungal β-1,3-glucan synthase FKS1
2023 StandoutNature
Works of Michael A. Pfaller being referenced
Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations
2013 Standout
In vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY303366, and other antifungal agents
1997
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Michael A. Pfaller | 48434 | 37065 | 8034 | 819 | 66.4k | |
| Thomas J. Walsh | 46980 | 38757 | 2289 | 760 | 61.8k | |
| Ronald N. Jones | 24973 | 20243 | 12681 | 1.3k | 55.3k | |
| Daniel J. Diekema | 22217 | 16767 | 4350 | 349 | 30.0k | |
| Po‐Ren Hsueh | 14841 | 12286 | 4011 | 960 | 36.9k | |
| David R. Andes | 20619 | 15218 | 1530 | 344 | 29.7k | |
| David L. Paterson | 14750 | 18555 | 7583 | 571 | 59.2k | |
| William R. Jarvis | 12437 | 10369 | 3676 | 469 | 40.1k | |
| Emilio Bouza | 15377 | 15559 | 3533 | 853 | 28.3k | |
| Julian Parkhill | 15800 | 11798 | 4433 | 561 | 54.7k | |
| Issam Raad | 13733 | 14839 | 4348 | 484 | 35.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...